Treadwell Therapeutics scores $27 mln seed

Treadwell Therapeutics, a clinical-stage oncology company, has secured $27 million in seed funding.

Treadwell Therapeutics, a clinical-stage oncology company, has secured $27 million in seed funding. The investor was TIO Bioventures.

Source: Press Release